Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 134.84 billion. The enterprise value is 146.41 billion.
| Market Cap | 134.84B |
| Enterprise Value | 146.41B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 23.42.
| PE Ratio | 23.42 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 6.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.25, with an EV/FCF ratio of 19.25.
| EV / Earnings | 25.44 |
| EV / Sales | 3.06 |
| EV / EBITDA | 11.25 |
| EV / EBIT | 15.17 |
| EV / FCF | 19.25 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.46 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.50 |
| Debt / FCF | 2.44 |
| Interest Coverage | 13.84 |
Financial Efficiency
Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 5.88%.
| Return on Equity (ROE) | 7.30% |
| Return on Assets (ROA) | 4.28% |
| Return on Invested Capital (ROIC) | 5.88% |
| Return on Capital Employed (ROCE) | 8.56% |
| Revenue Per Employee | 553,216 |
| Profits Per Employee | 69,455 |
| Employee Count | 82,878 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.48% in the last 52 weeks. The beta is 0.46, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +12.48% |
| 50-Day Moving Average | 110.46 |
| 200-Day Moving Average | 104.74 |
| Relative Strength Index (RSI) | 45.51 |
| Average Volume (20 Days) | 16,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 45.85 billion and earned 5.76 billion in profits. Earnings per share was 4.60.
| Revenue | 45.85B |
| Gross Profit | 32.19B |
| Operating Income | 9.18B |
| Pretax Income | 7.00B |
| Net Income | 5.76B |
| EBITDA | 12.08B |
| EBIT | 9.18B |
| Earnings Per Share (EPS) | 4.60 |
Balance Sheet
The company has 7.82 billion in cash and 18.55 billion in debt, giving a net cash position of -10.72 billion.
| Cash & Cash Equivalents | 7.82B |
| Total Debt | 18.55B |
| Net Cash | -10.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 80.61B |
| Book Value Per Share | 64.01 |
| Working Capital | 13.90B |
Cash Flow
In the last 12 months, operating cash flow was 9.40 billion and capital expenditures -1.79 billion, giving a free cash flow of 7.61 billion.
| Operating Cash Flow | 9.40B |
| Capital Expenditures | -1.79B |
| Free Cash Flow | 7.61B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.21%, with operating and profit margins of 20.03% and 12.55%.
| Gross Margin | 70.21% |
| Operating Margin | 20.03% |
| Pretax Margin | 15.26% |
| Profit Margin | 12.55% |
| EBITDA Margin | 26.34% |
| EBIT Margin | 20.03% |
| FCF Margin | 16.59% |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 84.60% |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.02% |
| Earnings Yield | 4.27% |
| FCF Yield | 5.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |